Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Two Different Botulinum Toxin Type A Treatments for Moderate to Severe Cervical Dystonia

NCT00432341 is registered in ClinicalTrials.gov with Allergan as lead sponsor.

NCT NCT00432341
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00432341 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Two Different Botulinum Toxin Type A Treatments for Moderate to Severe Cervical Dystonia
Lead sponsor
Allergan
Phase
Phase 4
Overall status
Terminated
Start date
June 30, 2007
Completion date
June 30, 2009
Enrollment
54 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

spasmodic torticollis